Eli Lilly & Co: (NYSE: LLY)
$55.07
0.05 (0.08%)
Volume 2,154,616
May 21 02:04 PM ET
Zacks Rank: 3-Hold 
| #3 |
Comparison to Industry
Industry / Sector Report
Industry: LARGE CAP PHARMA
Zacks Industry Rank: 
Rank in Industry:
Recommendations and Estimates
| Company | Industry | SP500 | |
|---|---|---|---|
| Average Recommendation (1=Buy, 5=Sell) | 2.74 | 2.08 | 9.99 |
| Current Quarter Estimate | 1.00 | 24.10 | 25.88 |
| Year Ago Quarter Estimate | 0.83 | 20.48 | 24.24 |
| Next Quarter Estimate | 0.94 | 24.67 | 26.63 |
| Next Year Estimate | 2.75 | 21.68 | 25.43 |
Growth Rates
| Company | Industry | SP500 | |
|---|---|---|---|
| This Year (15.4) | 15.40 | -3.40 | 11.40 |
| Next Year (-29.7) | -29.70 | 7.00 | 6.50 |
| Last 5 Years | -1.10 | 7.10 | 5.70 |
| Next 5 Years | -0.20 | 6.30 | NA |
Financials
| Company | Industry | ||
|---|---|---|---|
| Price/Earnings (TTM) | 15.24 | 16.01 | |
| Price/Book (MRQ) | 4.16 | 3.82 | |
| Price/Cash Flow (MRFY) | 12.16 | 12.20 | |
| Dividend Yield | 3.56% | 2.77% | |
| Net Profit Margin (TTM) | 20.45% | 15.61% | |
| Return on Equity (TTM) | 26.64% | 23.70% | |
| Debt to Equity (MRQ) | 0.30 | 25.20 |
MRQ = Most Recent Quarter TTM = Trailing Twelve Months MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.
